Use of polyunsaturated ketones for the treatment of psoriasis
AssigneeAvexxin AS
InventorsBerit Johansen, Marit Anthonsen, Wenche Sjursen, Anne Kristen Holmeide, Lars Skattebol
Life of this patent
Estimating the term…
Abstract
Psoriasis is a common, chronic, inflammatory skin disorder. This invention provides the use of a compound of formula (I) R—CO—X) (Wherein R is a C16-24 unsaturated hydrocarbon group optionally interrupted by α, β, γ, or δ to the carbonyl group by a heteroatom or group of heteroatoms selected from S, O, N, SO, SO2 said hydrocarbon group comprising at least 5 non-conjugated double bonds; and X is an electron withdrawing group) in the manufacture of a medicament for the treatment of psoriasis.
Claims1
A pharmaceutical composition comprising a compound of formula (I)
- R—CO—X (I),
- wherein R is a C16-24 unsaturated hydrocarbon group interrupted β or γ to the carbonyl group by one or more heteroatoms selected from the group consisting of S, 0, N, SO, and SO2, said hydrocarbon group comprising at least 5 non-conjugated double bonds;
- and X is an electron withdrawing group, wherein the pharmaceutical composition is a cream or ointment formulated for topical or intradermal use;
- wherein the compound of Formula (I) is
Dependencies are inferred from the claim text.